 |
|
|
|
 |
|
|
|
| Article 1 to 10 out of 323
|
|
-
Selvita appoints Dr. Nicolas D. Beuzen as Chief Scientific Officer and Member of the Management Board
(14 May 2008)
Selvita Sp. z o.o. announced the appointment of Dr. Nicolas D. Beuzen as its Chief Scientific Officer and Member of the Management Board. Dr. Beuzen will oversee all Selvita's drug research projects. After the first experience in 2002 as a ......
-
Genenews adds two members to its Board of Directors
(07 May 2008)
GeneNews Limited announced its shareholders recently elected two additional members to its Board of Directors, Mr. Harry A. Glorikian and Ms. Fran Tuttle. They join Mr. Rory Riggs, Mr. James Howard-Tripp, Mr. Garth MacRae, Dr. Heiner Dreismann, ......
-
Aesica appoints Michael Staff, Vice President, Sales and Business Development North Amercia
(06 May 2008)
Aesica establishes its commercial presence in the US
Aesica announced the appointment of Michael Staff as Vice President, Sales and Business Development, North America. Michael joins Aesica from Minakem, a French fine chemical company, where he was President and CEO of their US subsidiary. During ......
-
CollPlant developing Type I Recombinant Human Collagen from Transgenic Tobacco Plants
(06 May 2008)
CollPlant Ltd., a biotechnology company specializing in the development and commercialization of novel medical products based on its plant-derived, Type I collagen and other recombinant proteins, announced that they elected Mr. Ronny Barak as ......
-
Ablynx announces senior management change
(02 May 2008)
Ablynx has announced that Dr Hennie Hoogenboom will be stepping down from his position as Chief Scientific Officer and member of the Executive Committee. Dr Hoogenboom joined Ablynx in 2005 and has contributed significantly to building up the ......
-
MIGENIX Appoints Pieter Dorsman to Board of Directors
(24 Apr 2008)
MIGENIX Inc. has appointed Pieter Dorsman to its Board of Directors. Mr. Dorsman is President and a Director of Redpeaks Management, Inc., a financial consulting firm in Vancouver, which advises companies on finance and investment, corporate ......
-
Addex Appoints Laurent Massuyeau as Head of Business Development
(22 Apr 2008)
Addex Pharmaceuticals announced the appointment of Laurent Massuyeau as head of business development. Mr. Massuyeau joins Addex from Idenix Pharmaceuticals Inc., where he was executive director of European commercial operations. He brings to ......
-
Chemokine Therapeutics Announces New President And Chief Executive Officer
(18 Apr 2008)
Chemokine Therapeutics Corp. announced the appointment of Walter Korz as its new President and Chief Executive Officer (CEO). Mr. Korz succeeds Bashir Jaffer who held the position as Chief Executive Officer on an interim basis since December ......
-
Angiotech announces director resignation
(17 Apr 2008)
Angiotech Pharmaceuticals, Inc. announced the resignation of Greg Peet from his position as a non-executive director of the Company. Mr. Peet has resigned to enable him to focus on his numerous business pursuits and additional board ......
-
AEterna Zentaris Announces Changes to its Management Team
(15 Apr 2008)
AEterna Zentaris Inc. announced that David J. Mazzo, Ph.D., has resigned as President and Chief Executive Officer and as member of the Board of Directors of AEterna Zentaris, effective immediately. Mr. Juergen Ernst, the current Chairman of the ......
|
|
|
Top